Octagam

Type: Product
Name: Octagam
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

Safety information on the risk of blood clots with immunoglobulin products

OTTAWA, Oct. 9, 2014 /CNW/ - is informing Canadians that, following a safety review, the prescribing information (product monograph) for all immunoglobulin products has been updated to strengthen warnings on the rare but serious risk of blood clots.Immunoglobulins ... [Published Ask.com - Oct 09 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Octapharma gets FDA approval for immune thrombocytopenic purpura therapy Octagam 10%

Octapharma USA has received approval from the US Food and Drug Administration (FDA) for its Octagam 10% to treat adults with chronic immune thrombocytopenic purpura (ITP), a platelet disorder that can result in easy or excessive bruising and bleeding ... [Published PBR - News - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Octapharma USA Announces FDA Approval of Octagam 10%, Expanding Its Immune Globulin Therapy Portfolio

HOBOKEN, N.J.--(BUSINESS WIRE)--Octapharma announces FDA approval of Octagam 10% [Immune Globulin Intravenous (Human) 10% (100 mg/mL) Liquid Preparation] for the treatment of adults with chronic Immune Thrombocytopenic Purpura (ITP) ... [Published Business Wire Health News - Jul 15 2014]

More Content

All (3) | News (1) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Safety information on the risk of blood clots w... [Published Ask.com - Oct 09 2014]
Octapharma gets FDA approval for immune thrombo... [Published PBR - News - Jul 17 2014]
Octapharma USA Announces FDA Approval of Octaga... [Published Business Wire Health News - Jul 15 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Octapharma gets FDA approval for immune thrombo... [Published PBR - News - Jul 17 2014]
Octapharma USA has received approval from the US Food and Drug Administration (FDA) for its Octagam 10% to treat adults with chronic immune thrombocytopenic purpura (ITP), a platelet disorder that can result in easy or excessive bruising and bleeding ...
Octapharma USA Announces FDA Approval of Octaga... [Published Business Wire Health News - Jul 15 2014]
HOBOKEN, N.J.--(BUSINESS WIRE)--Octapharma announces FDA approval of Octagam 10% [Immune Globulin Intravenous (Human) 10% (100 mg/mL) Liquid Preparation] for the treatment of adults with chronic Immune Thrombocytopenic Purpura (ITP) ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.